Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:912-918
Published online before print March 17, 2003, doi: 10.1161/01.HYP.0000063883.83470.7B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/4/912    most recent
01.HYP.0000063883.83470.7Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gschwend, S.
Right arrow Articles by Buikema, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gschwend, S.
Right arrow Articles by Buikema, H.
Related Collections
Right arrow Hypertension - basic studies
Right arrow Ion channels/membrane transport
Right arrow Coronary circulation
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Hypertension. 2003;41:912.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Coronary Myogenic Constriction Antagonizes EDHF-Mediated Dilation

Role of KCa Channels

Simone Gschwend; Robert H. Henning; Dick de Zeeuw; Hendrik Buikema

From the Institute of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands.

Correspondence to Simone Gschwend, Department of Clinical Pharmacology, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands. E-mail s.gschwend{at}med.rug.nl

In hypertension, pressure-induced myogenic constriction and impaired endothelium-derived hyperpolarizing factor (EDHF)-mediated dilation may contribute to increased vasomotor tone. Myogenic constriction as well as EDHF-mediated dilation may share common signaling mechanisms, and both may control KCa channel activity to set arterial tone. To investigate a potential relation between the 2 mechanisms, we studied coronary arteries of Sprague-Dawley rats for individual myogenic constriction compared with EDHF-mediated dilation of the same artery. EDHF-mediated dilation was measured as the maximal dilation to acetylcholine (100 µmol/L) after preconstriction, resistant to NO inhibition (NG-methyl-L-arginine acetate salt, L-NMMA, 100 µmol/L), and prostaglandin inhibition (indomethacin, 10 µmol/L) but abolished by charybdotoxin (100 nmol/L) plus apamin (500 nmol/L). Individual coronary myogenic constriction at an intraluminal pressure of 70 mm Hg (n=9) ranged from 6% to 44% (24±4%). EDHF-mediated dilation ranged from 18% to 84% (42±7%). Elevating pressure to 130 mm Hg (n=8) increased myogenic constriction by 2-fold (P<0.01) and decreased EDHF-mediated dilation by 2.6-fold (P<0.01). Interestingly, individual myogenic constriction inversely correlated to individual EDHF-mediated dilation (r=-0.75, P<0.001, n=17). Pretreatment with the KCa channel opener NS1619 (30 µmol/L) prevented coronary myogenic constriction and increased EDHF-mediated dilation by 2.2-fold (P<0.01), whereas the KATP channel opener cromakalim (3 µmol/L) had no effect on EDHF-mediated dilation. For comparison, in mesenteric arteries (at 70 mm Hg) low myogenic constriction (2±1%) was associated with high EDHF-mediated dilation (93±2%), and pretreatment with NS1619 had no effect. Our results demonstrate that myogenic constriction in coronary arteries antagonizes EDHF-mediated dilation. Activation of KCa channels with NS1619 reduces myogenic constriction and profoundly increases EDHF-mediated dilation, specifically in coronary arteries, suggesting a potential therapeutic impact to reduce coronary risk in hypertension.


Key Words: acetylcholine • autoregulation • endothelium-derived factors • constriction • potassium channels • vasodilation




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
Y. Xu, R.H. Henning, E. Lipsic, A. van Buiten, W.H. van Gilst, and H. Buikema
Acetylcholine stimulated dilatation and stretch induced myogenic constriction in mesenteric artery of rats with chronic heart failure
Eur J Heart Fail, February 1, 2007; 9(2): 144 - 151.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-Y. Dong, M. Wu, A. P.C. Yim, and G.-W. He
Hypoxia-Reoxygenation, St. Thomas Cardioplegic Solution, and Nicorandil on Endothelium-derived Hyperpolarizing Factor in Coronary Microarteries
Ann. Thorac. Surg., November 1, 2005; 80(5): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Huang, D. Sun, C. Yan, J. R. Falck, and G. Kaley
Contribution of 20-HETE to Augmented Myogenic Constriction in Coronary Arteries of Endothelial NO Synthase Knockout Mice
Hypertension, September 1, 2005; 46(3): 607 - 613.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Randriamboavonjy, L. Kiss, J. R. Falck, R. Busse, and I. Fleming
The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation
Cardiovasc Res, February 1, 2005; 65(2): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. A. Kocks, S. Gschwend, D. de Zeeuw, G. Navis, and H. Buikema
Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1183 - 1189.
[Abstract] [Full Text] [PDF]